Superficial community-acquired skin infections: Prevalence of bacteria and antibiotic susceptibility in France

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 12, 2009, Pages 1423-1426

  Lorette, G ^a   Beaulieu, P H ^b   Allaert, F A ^c   Mahmoudi, A ^d   Jarlier, V ^e  

^a UNIVERSITÉ DE TOURS   (France)

^b Fed Française de Form Continue en Dermato Venerologie FFFCEDV General Secretary JP Claudel ^*  (France)

^c BURGUNDY SCHOOL OF BUSINESS   (France)

^d SAS   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Mupirocin; Pristinamycin; Staphylococcus aureus; Superficial community acquired skin infection

Indexed keywords

FUSIDIC ACID; METICILLIN; PENICILLIN G; PRISTINAMYCIN; PSEUDOMONIC ACID; QUINOLONE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL EVALUATION; COMMUNITY; CONSULTATION; CONTROLLED STUDY; ECTHYMA; EPIDEMIOLOGICAL DATA; FOLLICULITIS; FRANCE; FURUNCULOSIS; HUMAN; IMPETIGO; LABORATORY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FRANCE; HUMANS; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; PREVALENCE; PRISTINAMYCIN; SKIN DISEASES, BACTERIAL;

EID: 70449460874     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03352.x     Document Type: Article

References (15)

1. Del Guidice P, Blanc V, Etienne J. Les infections àStaphylococcus aureus résistants en ville: les dermatologues en première ligne!. Ann Dermatol Venereol 2007 134 : 317 320.
2. Lorette G, Beaulieu P, Bismuth R et al. Infections cutanées communautaires. Bactéries en cause et sensibilité aux antibiotiques. Ann Dermatol Venereol 2003 130 : 723 728.
3. Del Guidice P, Blanc V, Durupt F et al. Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br J Dermatol 2006 154 : 118 124.
4. Fridkin SK, Hageman JC, Morrison M et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005 352 : 1436 1444.
5. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med 2006 355 : 666 674.
6. Aramburu C, Harbarth S, Liassine N et al. Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland: first surveillance report. Euro Surveill 2006 11 : 42 43.
7. Asencio A, Canton R, Vaque J et al. Nosocomial and community-acquired methicillin-resistant Staphylococcus aureus infections in hospitalized patients (Spain, 1993-2003). J Hosp Infect 2006 63 : 465 471.
8. Ho PL, Chuang SK, Choi YF et al. Community-associated methicillin-resistant and methicillin-sensitive Staphylococcus aureus: skin and soft tissue infections in Hong Kong. Diagn Microbiol Infect Dis 2008 61 : 245 250.
9. Nimmo GR, Coombs GW. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents 2008 31 : 401 410.
10. Dagan R, Bar-David Y. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 1992 36 : 287 290.
11. Koning S, Van Suijlekom-Smit LWA, Nouwen JL et al. Fusidic acid cream in the treatment of impetigo in general practice: double-blind randomised placebo controlled trial. BMJ 2002 324 : 203 206. (Pubitemid 34107085)
12. Rogers M, Dorman DC, Gapes M, Ly J. A three-year study of impetigo in Sydney. Med J Aust 1987 147 : 63 65.
13. Olivier C. Infections cutanées sévères àStreptococcus pyogenes. Arch Pediatr 2001 8 : 757 761.
14. Berlau J, Aucken H, Malnick H, Pitt T. Distribution of Acinetobacter species on skin of healthy humans. Eur J Clin Microbiol Infect Dis 1999 18 : 179 183.
15. Zichichi L, Astra G, Noto G. Pseudomonas aeruginosa folliculitis after shower/bath exposure. Int J Dermatol 2000 39 : 270 273.